Publications by authors named "Andrew D Napper"

Claim this Profile
P
Perspectives on phenotypic screening-Screen Design and Assay Technology Special Interest Group.
Chorom Pak, Kaylene J Simpson, Andrea D Weston, Mary Ellen Cvijic, Kenda Evans, Andrew D Napper

SLAS Discov· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a High-Throughput Pilot Screen in Peptide Hydrogel-Based Three-Dimensional Cell Cultures.
Peter Worthington, Katherine M Drake, Zhiqin Li, Andrew D Napper, Darrin J Pochan

SLAS Discov· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-hairpin hydrogels as scaffolds for high-throughput drug discovery in three-dimensional cell culture.
Peter Worthington, Katherine M Drake, Zhiqin Li, Andrew D Napper, Darrin J Pochan

Anal Biochem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome Patient.
Donna M Cartledge, Katherine M Robbins, Katherine M Drake, Rachel Sternberg, Deborah L Stabley, Andrew D Napper

Front Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Special Focus on Drug Repurposing, Rescue, and Repositioning.
Andrew D Napper, Hermann A M Mucke

Assay Drug Dev Technol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discriminating High-Value Hits from PAINS.
Andrew D Napper

Assay Drug Dev Technol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interview with Jonathan Baell, PhD.
Andrew D Napper

Assay Drug Dev Technol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new chapter for ASSAY and drug development technologies.
Andrew D Napper

Assay Drug Dev Technol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives in ASSAY and Drug Development Technologies.
Andrew D Napper

Assay Drug Dev Technol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interview with Haian Fu, PhD.
Haian Fu, Andrew D Napper

Assay Drug Dev Technol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversies in ASSAY and drug development technologies: a focus on assessing irreproducibility.
J Fraser Glickman, Thomas Lundbäck, Andrew D Napper, Walter D Niles, Anton Simeonov

Assay Drug Dev Technol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sensitive luminescent assay for the histone methyltransferase NSD1 and other SAM-dependent enzymes.
Katherine M Drake, Venita G Watson, Anne Kisielewski, Rebecca Glynn, Andrew D Napper

Assay Drug Dev Technol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted drug discovery for pediatric leukemia.
Andrew D Napper, Venita G Watson

Front Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a high-throughput screening-compatible assay for the discovery of inhibitors of the AF4-AF9 interaction using AlphaScreen technology.
Venita Gresham Watson, Katherine M Drake, Yu Peng, Andrew D Napper

Assay Drug Dev Technol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening.
Catherine Moorwood, Olga Lozynska, Neha Suri, Andrew D Napper, Scott L Diamond

PLoS One· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of specific inhibitors of human RAD51 recombinase using high-throughput screening.
Fei Huang, Nuzhat A Motlekar, Chelsea M Burgwin, Andrew D Napper, Scott L Diamond

ACS Chem Biol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Miniaturized High-Throughput Fluorescent Assay for Conversion of NAD(P)H to NAD(P).
Andrew D Napper, Sharmila Sivendran

Curr Protoc Chem Biol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms.
Michael D LaFleur, Edinson Lucumi, Andrew D Napper, Scott L Diamond, Kim Lewis

J Antimicrob Chemother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel High-Throughput Automated Assays to Measure Cell Growth and Beta-Galactosidase Reporter Gene Expression in the Yeast Saccharomyces cerevisiae.
Andrew D Napper, Nuzhat Motlekar, Rogerio Alves de Almeida, Graham D Pavitt

Curr Protoc Chem Biol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
Edinson Lucumi, Claire Darling, Hyunil Jo, Andrew D Napper, Rajesh Chandramohanadas

Antimicrob Agents Chemother· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Society for biomolecular sciences - 16th annual conference & exhibition - advancing the science of drug discovery.
Andrew D Napper

IDrugs· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC).
Sharmila Sivendran, Victoria Jones, Dianqing Sun, Yi Wang, Anna E Grzegorzewicz, Andrew D Napper

Bioorg Med Chem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of chemical modulators of a conserved translational control pathway by parallel screening in yeast.
Nuzhat Motlekar, Rogerio Alves de Almeida, Graham D Pavitt, Scott L Diamond, Andrew D Napper

Assay Drug Dev Technol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
Andrew D Napper

IDrugs· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An interview with Andrew D. Napper, Ph.D. Interview.
Andrew D Napper

Assay Drug Dev Technol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis